Biotech

All Articles

Turnstone lays off 60%, agitates C-suite to stretch out cash money

.Turnstone Biologics is lowering its own headcount through 60% as well as agitating its C-suite if y...

Gilead quits on $15M MASH wager after mulling preclinical data

.In a year that has viewed a permission and also a boating of readouts for metabolic dysfunction-ass...

Texas biotech centers cancer cells contract, pins hopes on obesity

.Alaunos Rehabs is axing a contract along with Precigen, surrendering licensing legal rights to an i...

Capricor portions even more records for DMD treatment after initiating BLA

.Capricor Therapies is taking a victory tour for their period 2 Duchenne muscular dystrophy (DMD) tr...

FDA locations Kezar lupus test in grip adhering to 4 person fatalities

.The FDA has put Kezar Life Sciences' lupus test on grip after the biotech hailed four deaths throug...

Phase 3 Academic Stone test hits SMA target, delivering stock up 200%

.A stage 3 trial of Academic Rock's back muscle degeneration (SMA) prospect has actually attacked it...

CAMP 4 is actually most current to eye IPO, while Upstream spells out $182M strategy

.RNA biotech CAMP4 Therapeutics has defined plans for a $67 thousand IPO, with inflammation-focused ...

Galecto purchases leukemia medication, drops bone cancer cells resource in pivot

.A year after the failure of an idiopathic pulmonary fibrosis prospect sent out Galecto on a hunt fo...

Judo tosses down $100M to knock senseless kidney illness

.Taking the mat is Judo Bio, an ambitious biotech armed with $one hundred thousand to develop oligon...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has paid off CSPC Pharmaceutical Group $100 million for a preclinical cardiovascular di...